West Pharma SVP & Chief Commercial Officer departs; severance agreed

WEST PHARMACEUTICAL SERVICES INC

Cindy Reiss-Clark left as SVP and Chief Commercial Officer on March 7, 2025.
Severance includes 52-week salary continuation ($489,500), pro-rated AIP ($57,526), and $15K outplacement.
Agreement includes a full release, noncompetition, nonsolicitation, and nondisparagement covenants.
Equity vesting ends March 7, 2025; 2024 AIP bonus of $42,476 to be paid.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Cindy Reiss-Clark

Senior Vice President and Chief Commercial Officer

WST · WEST PHARMACEUTICAL SERVICES INC

Effective: 2025-03-07
Filed: April 14, 2025, 7:59 PM ET

On March 7, 2025, West Pharmaceutical Services, Inc. (the “Company”) announced that Cindy Reiss-Clark, former Senior Vice President and Chief Commercial Officer, departed from the Company effective that same date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cindy Reiss-Clark departed as Senior Vice President and Chief Commercial Officer at WEST PHARMACEUTICAL SERVICES INC.

Action: departed
Role: Senior Vice President and Chief Commercial Officer

Exact text from the filing

On March 7, 2025, West Pharmaceutical Services, Inc. (the “Company”) announced that Cindy Reiss-Clark, former Senior Vice President and Chief Commercial Officer, departed from the Company effective that same date.

View on SEC.gov

WEST PHARMACEUTICAL SERVICES INC filing history →

Source: SEC EDGAR

accession 0000105770-25-000022

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.